BR9205879A - Composição antimicrobiana, composição adesiva, processo de tratamento de infecção em mamífero e processo para conferir proteção antimicrobiana a um paciente - Google Patents

Composição antimicrobiana, composição adesiva, processo de tratamento de infecção em mamífero e processo para conferir proteção antimicrobiana a um paciente

Info

Publication number
BR9205879A
BR9205879A BR9205879A BR9205879A BR9205879A BR 9205879 A BR9205879 A BR 9205879A BR 9205879 A BR9205879 A BR 9205879A BR 9205879 A BR9205879 A BR 9205879A BR 9205879 A BR9205879 A BR 9205879A
Authority
BR
Brazil
Prior art keywords
antimicrobial
composition
host
patient
infection treatment
Prior art date
Application number
BR9205879A
Other languages
English (en)
Inventor
Christopher C Capelli
Original Assignee
Christopher C Capelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christopher C Capelli filed Critical Christopher C Capelli
Publication of BR9205879A publication Critical patent/BR9205879A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46D—MANUFACTURE OF BRUSHES
    • A46D1/00—Bristles; Selection of materials for bristles
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46D—MANUFACTURE OF BRUSHES
    • A46D1/00—Bristles; Selection of materials for bristles
    • A46D1/006—Antimicrobial, disinfectant bristles, handle, bristle-carrier or packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B42/00—Surgical gloves; Finger-stalls specially adapted for surgery; Devices for handling or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
BR9205879A 1991-04-10 1992-04-09 Composição antimicrobiana, composição adesiva, processo de tratamento de infecção em mamífero e processo para conferir proteção antimicrobiana a um paciente BR9205879A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68343691A 1991-04-10 1991-04-10
PCT/US1992/002669 WO1992018098A1 (en) 1991-04-10 1992-04-09 Antimicrobial compositions useful for medical applications

Publications (1)

Publication Number Publication Date
BR9205879A true BR9205879A (pt) 1994-07-05

Family

ID=24744037

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205879A BR9205879A (pt) 1991-04-10 1992-04-09 Composição antimicrobiana, composição adesiva, processo de tratamento de infecção em mamífero e processo para conferir proteção antimicrobiana a um paciente

Country Status (9)

Country Link
US (1) US5326567A (pt)
EP (1) EP0580803B1 (pt)
JP (1) JPH06506694A (pt)
AT (1) ATE181822T1 (pt)
AU (1) AU656384B2 (pt)
BR (1) BR9205879A (pt)
CA (1) CA2108008C (pt)
DE (1) DE69229548T2 (pt)
WO (1) WO1992018098A1 (pt)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662913A (en) * 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
US5593438A (en) * 1995-01-20 1997-01-14 Akhavi; David S. Intraocular lens with metallic coatings for preventing secondary cataracts
AU750719B2 (en) * 1995-06-30 2002-07-25 Christopher C. Capelli Silver-based pharmaceutical compositions
CA2225808C (en) * 1995-06-30 2002-12-17 Christopher C. Capelli Silver-based pharmaceutical compositions
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US6861570B1 (en) * 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US5814094A (en) 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US6087549A (en) 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
US8455710B2 (en) 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US6060534A (en) 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6368356B1 (en) 1996-07-11 2002-04-09 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
US5820918A (en) * 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
US6093414A (en) * 1997-08-11 2000-07-25 Christopher C. Capelli Silver-based antimicrobial compositions
EP0860213A3 (de) 1997-01-03 2002-10-16 Therapol SA Bioaktive Beschichtung von Oberflächen
DE19716606A1 (de) * 1997-04-21 1998-10-22 Huels Chemische Werke Ag Bakterienabweisend und blutverträglich modifizierte Oberflächen
EP0893165A3 (de) 1997-06-28 2000-09-20 Degussa-Hüls Aktiengesellschaft Bioaktive Beschichtung von Oberflächen unter Verwendung von Makroinitiatoren
DE19727554A1 (de) * 1997-06-28 1999-01-07 Huels Chemische Werke Ag Verfahren zur Hydrophilierung der Oberfläche polymerer Substrate mit einem Makroinitiator als Primer
US6153210A (en) * 1997-08-14 2000-11-28 Periodontix, Inc. Use of locally delivered metal ions for treatment of periodontal disease
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
US6468521B1 (en) 1998-08-14 2002-10-22 Coloplast A/S Stabilized compositions having antibacterial activity
US6596401B1 (en) 1998-11-10 2003-07-22 C. R. Bard Inc. Silane copolymer compositions containing active agents
US6676951B1 (en) * 1999-05-11 2004-01-13 Charles Walton Champ Host-guest processes and formulations for delivering bio-affecting compounds
WO2000067726A1 (en) * 1999-05-11 2000-11-16 Charles Walton Champ Host-guest processes and formulations for delivering bio-affecting compounds
US20040228887A1 (en) * 1999-05-11 2004-11-18 Champ Charles W. Host-guest processes and formulations for delivering bio-affecting compounds
EP1066825A1 (en) * 1999-06-17 2001-01-10 The Procter & Gamble Company An anti-microbial body care product
US6383273B1 (en) 1999-08-12 2002-05-07 Apyron Technologies, Incorporated Compositions containing a biocidal compound or an adsorbent and/or catalyst compound and methods of making and using therefor
US6579469B1 (en) 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
JP2001151681A (ja) 1999-11-24 2001-06-05 Lintec Corp 消化器系疾患の予防および／または治療剤
US7179849B2 (en) * 1999-12-15 2007-02-20 C. R. Bard, Inc. Antimicrobial compositions containing colloids of oligodynamic metals
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6579539B2 (en) 1999-12-22 2003-06-17 C. R. Bard, Inc. Dual mode antimicrobial compositions
EP1244476B1 (en) * 1999-12-30 2006-05-31 Acrymed Methods and compositions for improved delivery devices
WO2001074300A1 (en) * 2000-03-30 2001-10-11 Brennen Medical, Inc. Anti-microbial and immunostimulating composition
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
ES2231550T3 (es) * 2000-09-29 2005-05-16 Coloplast A/S Composiciones estabilizadas que poseen actividad antibacteriana.
ATE468120T1 (de) * 2000-11-29 2010-06-15 Convatec Technologies Inc Lichtstabilisierte antimikrobielle mittel
US7157614B1 (en) * 2000-12-21 2007-01-02 Fountainhead, Llc Treatment devices providing targeted antimicrobial action
JP4413465B2 (ja) * 2001-02-28 2010-02-10 敏郎 渡辺 銀系抗菌剤
US6913765B2 (en) 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
US7820284B2 (en) 2001-12-03 2010-10-26 C.R. Bard Inc. Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
FR2838295B1 (fr) * 2002-04-15 2005-05-13 Georgia Pacific France Utilisation de sels metalliques du gluconate pour la fabrication de substrats a activite antimicrobienne
AU2003227431B2 (en) * 2002-06-28 2008-08-14 S.T. Corporation Moisture retentive gloves and process for producing the same
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
GB0222259D0 (en) * 2002-09-25 2002-10-30 First Water Ltd Antimicrobial compositions
US7285576B2 (en) * 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
US7147845B2 (en) * 2003-04-23 2006-12-12 Biointerface Technologies, Inc. Antimicrobial silver ion complex resinates
US6923990B2 (en) * 2003-04-23 2005-08-02 Christopher Capelli Stabilized silver-ion amine complex compositions and methods
GB2408206B (en) * 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005055723A1 (en) * 2003-12-04 2005-06-23 The University Of Iowa Research Foundation Gallium inhibits biofilm formation
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US7745509B2 (en) * 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050266081A1 (en) * 2004-05-26 2005-12-01 Rogozinski Wallace J Antimicrobial silver hydrogels
EP1781098B1 (en) * 2004-07-30 2015-10-07 Avent, Inc. Antimicrobial devices and compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US8900610B2 (en) * 2004-08-30 2014-12-02 Southwest Research Institute Biocidal fibrous and film materials comprising silver and chlorite ions
WO2006026573A2 (en) * 2004-08-30 2006-03-09 Southwest Research Institute Biocidal fibrous and film materials utilizing silver ion
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
EP1809264B1 (en) * 2004-09-20 2016-04-13 Avent, Inc. Antimicrobial amorphous compositions
MX2007010906A (es) 2005-03-10 2007-12-05 3M Innovative Properties Co Metodos para reducir la contaminacion microbiana.
KR20070113281A (ko) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
JP2008533048A (ja) 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
US8399027B2 (en) * 2005-04-14 2013-03-19 3M Innovative Properties Company Silver coatings and methods of manufacture
GB2425474A (en) * 2005-04-26 2006-11-01 Ethicon Inc Photostable wound dressing materials and methods of production thereof
US8840876B2 (en) * 2005-05-19 2014-09-23 Ethicon, Inc. Antimicrobial polymer compositions and the use thereof
US20060264347A1 (en) * 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition
US20060263444A1 (en) * 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition
US20070292469A1 (en) * 2005-07-25 2007-12-20 Rothenburger Stephen J Antimicrobial composition
CN101484178A (zh) * 2005-11-01 2009-07-15 赛德罗米克斯有限责任公司 使用镓化合物的口部和表面微生物的生长控制
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20070166399A1 (en) 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20070219516A1 (en) * 2006-03-14 2007-09-20 Tyco Healthcare Group Lp X-ray detectable element for association with surgical absorbent substrates and method of making
US8604073B2 (en) * 2006-03-27 2013-12-10 Ethicon, Inc. Antimicrobial composition
EP2015722B1 (en) * 2006-04-28 2016-11-16 Avent, Inc. Antimicrobial site dressings
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
MX2009004030A (es) * 2006-10-18 2009-04-27 3M Innovative Properties Co Articulos antimicrobianos y metodos de fabricacion.
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
CA2678873C (en) 2007-02-19 2016-10-25 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
US8734718B2 (en) 2007-08-17 2014-05-27 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component
US8702640B2 (en) 2007-08-17 2014-04-22 The Invention Science Fund I, Llc System, devices, and methods including catheters configured to monitor and inhibit biofilm formation
US8460229B2 (en) 2007-08-17 2013-06-11 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having components that are actively controllable between transmissive and reflective states
US8029740B2 (en) 2008-07-11 2011-10-04 The Invention Science Fund I, Llc Event-triggered self-sterilization of article surfaces
US8647292B2 (en) 2007-08-17 2014-02-11 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states
US8753304B2 (en) 2007-08-17 2014-06-17 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter
US8162924B2 (en) * 2007-08-17 2012-04-24 The Invention Science Fund I, Llc System, devices, and methods including actively-controllable superoxide water generating systems
US8114346B2 (en) * 2007-08-17 2012-02-14 The Invention Science Fund I, Llc Event-triggered ultraviolet light sterilization of surfaces
US20090048648A1 (en) * 2007-08-17 2009-02-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Self-sterilizing device
US8366652B2 (en) * 2007-08-17 2013-02-05 The Invention Science Fund I, Llc Systems, devices, and methods including infection-fighting and monitoring shunts
US8706211B2 (en) 2007-08-17 2014-04-22 The Invention Science Fund I, Llc Systems, devices, and methods including catheters having self-cleaning surfaces
US20090202658A1 (en) * 2008-02-08 2009-08-13 Cuero Raul G Versatile antimicrobial agent and uses thereof
RU2513142C2 (ru) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Способ лечения хронических ран
CN102238969A (zh) * 2008-09-22 2011-11-09 特莱奥辛控股公司 新的碘化树脂制造方法和产品
WO2010042427A2 (en) * 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Antimicrobial composition and methods of making and using same
MX2011005436A (es) * 2008-11-24 2011-11-04 Kimberly Clark Co Constructos laminados antimicrobianos.
US20110295090A1 (en) 2008-12-04 2011-12-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems, devices, and methods including implantable devices with anti-microbial properties
US8585627B2 (en) 2008-12-04 2013-11-19 The Invention Science Fund I, Llc Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure
WO2010065135A1 (en) 2008-12-04 2010-06-10 Searete, Llc System, devices, and methods including actively-controllable sterilizing excitation delivery implants
US8980243B2 (en) 2009-05-19 2015-03-17 Neal Koller Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
US9232805B2 (en) 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
US9052289B2 (en) * 2010-12-13 2015-06-09 Schlumberger Technology Corporation Hydrogen sulfide (H2S) detection using functionalized nanoparticles
AU2012253476B2 (en) 2011-05-10 2015-09-24 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
US9101678B2 (en) 2011-11-03 2015-08-11 Elwha Llc Heat-sanitization of surfaces
MX2015007771A (es) 2012-12-20 2015-09-04 Convatec Technologies Inc Procesamiento de fibras celulosicas quimicamente modificadas.
US9259501B2 (en) 2013-03-15 2016-02-16 Al Santelli, JR. Antimicrobial nasal insert and method of manufacturing
CN104016923B (zh) * 2014-01-08 2016-08-31 南开大学 苯妥英衍生物及其制备方法和用途
AU2016209327A1 (en) 2015-01-20 2017-08-10 Plurogen Therapeutics, Llc Compositions and methods of treating microbes
CN105288631B (zh) * 2015-11-17 2018-10-30 杭州普施康生物科技有限公司 一种新型抗癌药物纳米制剂及其制备方法
EP3407926A2 (en) * 2016-01-25 2018-12-05 Smith & Nephew, Inc. Orthopaedic implant
CN106633810A (zh) * 2016-10-31 2017-05-10 湖南科技大学 一种活性炭基特种合成纸的制备方法
CN106633808A (zh) * 2016-10-31 2017-05-10 湖南科技大学 一种蛋壳粉基合成纸的制备方法
EP4062949A1 (en) * 2021-03-24 2022-09-28 Mölnlycke Health Care AB Absorbent antimicrobial wound dressings with improved properties and reduced discoloration

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1093079B (de) * 1955-09-26 1960-11-17 Bayer Ag Verfahren zur Herstellung von keimhemmend bzw. keimtoetend ausgeruesteten Polyurethan-Schaumstoffen
US3092552A (en) * 1958-05-19 1963-06-04 Albert C Nolte Oligodynamic silver compositions and uses
US3639575A (en) * 1968-06-19 1972-02-01 Basf Wyandotte Corp Silver ion gel compositions and method of using the same
US3531433A (en) * 1968-09-30 1970-09-29 Gen Tire & Rubber Co Microbe-inhibited polyesterurethanes
US3645950A (en) * 1969-03-28 1972-02-29 Union Carbide Corp Stabilization of poly(ethylene oxide)
US4054139A (en) * 1975-11-20 1977-10-18 Crossley Kent B Oligodynamic catheter
DE2809244A1 (de) * 1977-03-04 1978-09-21 Nitto Electric Ind Co Antibakterielles und fungizides material
ZA785996B (en) * 1977-11-03 1979-09-26 Ici Ltd Polymers
EP0011471B1 (en) * 1978-11-17 1983-02-09 SMITH & NEPHEW RESEARCH LIMITED Adhesive-coated sheet material incorporating anti-bacterial substances
US4579731A (en) * 1979-01-11 1986-04-01 Key Pharmaceuticals, Inc. Polymeric diffusion burn matrix and method of use
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
US4654334A (en) * 1980-10-08 1987-03-31 International Minerals & Chemical Corp. Manganese-containing antibiotic agents
US4376764A (en) * 1981-08-10 1983-03-15 Basf Wyandotte Corporation Silver ion gel compositions
US4451635A (en) * 1982-03-08 1984-05-29 Tyndale Plains-Hunter, Ltd. Polyurethane quaternary ammonium salts
US4603152A (en) * 1982-11-05 1986-07-29 Baxter Travenol Laboratories, Inc. Antimicrobial compositions
US4588400A (en) * 1982-12-16 1986-05-13 Johnson & Johnson Products, Inc. Liquid loaded pad for medical applications
US4563184A (en) * 1983-10-17 1986-01-07 Bernard Korol Synthetic resin wound dressing and method of treatment using same
US4581028A (en) * 1984-04-30 1986-04-08 The Trustees Of Columbia University In The City Of New York Infection-resistant materials and method of making same through use of sulfonamides
US4587310A (en) * 1985-06-03 1986-05-06 The Dow Chemical Company Carbonate polymes containing a polyether polyol metal salt complex
DE3523023A1 (de) * 1985-06-27 1987-01-08 Ruhland Nachf Gmbh Dr Silberhaltige kollagenschwaemme oder kollagenfascien und deren verwendung zur herstellung eines abdeckmaterials fuer hautlaesionen
US4693992A (en) * 1985-08-26 1987-09-15 International Minerals & Chemical Corp. Bacitracin-metal-polyether antibiotic complexes
US4728323A (en) * 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
US4843138A (en) * 1988-02-08 1989-06-27 The Firestone Tire & Rubber Company Polyureaurethanes having improved low temperature properties based on high molecular weight polyether intermediates
JP2690505B2 (ja) * 1988-06-01 1997-12-10 旭化成工業株式会社 銅イオン及び／又は銀イオンを含む透湿性フイルム
US4933178A (en) * 1988-10-07 1990-06-12 Biointerface Technologies, Inc. Metal-based antimicrobial coating
US5045601A (en) * 1989-06-13 1991-09-03 Biointerface Technologies, Inc. Pressure-sensitive adhesive compositions suitable for medical uses

Also Published As

Publication number Publication date
EP0580803B1 (en) 1999-07-07
JPH06506694A (ja) 1994-07-28
CA2108008C (en) 1999-05-04
DE69229548T2 (de) 2000-02-17
EP0580803A1 (en) 1994-02-02
AU1875992A (en) 1992-11-17
DE69229548D1 (de) 1999-08-12
US5326567A (en) 1994-07-05
ATE181822T1 (de) 1999-07-15
CA2108008A1 (en) 1992-10-11
AU656384B2 (en) 1995-02-02
EP0580803A4 (en) 1995-04-19
WO1992018098A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
BR9205879A (pt) Composição antimicrobiana, composição adesiva, processo de tratamento de infecção em mamífero e processo para conferir proteção antimicrobiana a um paciente
PT772600E (pt) Compostos de imidazolilo substituido nas posicoes 1 e 2 para o tratamento da inflamacao
ATE47784T1 (de) Verwendung von alkylglykosiden als potenzierungsmittel in antiseptischen mitteln sowie desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung.
ES2096215T3 (es) Tucaresol como agente inmunopotenciador.
ES8505673A1 (es) Procedimiento para preparar derivados de 4-oxo-1, 4-dihidroquinoleina
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ATE194987T1 (de) Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden
FI102964B1 (fi) Terapeuttisia yhdisteitä
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
FI923664A0 (fi) Piperidinderivat.
DE69507694D1 (de) Trinukleare kationische platinkomplexe mit antitumor wirkung sowie diese enthaltende pharmazeutische zusammensetzungen
KR930009612A (ko) 바이러스-유리된 트롬빈 농축물 제조방법
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
FI923662A (fi) Terapeutiska medel
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
BR8906802A (pt) Processo para preparar composto contendo agrupamento de guanidina ou amidina substituidas
ATE133638T1 (de) Bakterienhemmende zusammensetzungen
ATE131382T1 (de) Mittel zur topischen behandlung von verbrennungen
DE3874142D1 (de) Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs.
BR9806923A (pt) Composto de terbenzimidazol, uso do mesmo, composi;cão farmacêutica, e, processo teapêutico.
SE9202434D0 (sv) Skatolinaktiverande komposition

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61L 31/16 (2006.01), A46D 1/00 (2006.0